Key facts
- Cylerity’s last known valuation is $10.6M (Oct 2025).
- It has raised $4.2M; the latest was Later Stage VC ($10.0M) in Oct 2025.
- Notable investors include Creative Destruction Lab, HealthX Ventures, AmberShore Group, C2 Ventures, Tundra Angels — 7 tracked in total.
- 1 investment vehicle was formed to buy Cylerity shares in the last 12 months, reporting $131K sold to 9 investors, per SEC Form D filings.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Cylerity
- ·The full record, as it builds
Funding rounds
No funding rounds for Cylerity are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Secondary demand: investment vehicles
from SEC Form D filingsIn the last 12 months, 1 investment vehicle were formed to buy Cylerity shares, reporting $131K sold to 9 investors. Most recent filing Jan 2026. Vehicles like these are how secondary buyers pool demand for a name; a rising count is a demand signal.
About Cylerity
Developer of a financial technology platform designed to accelerate cash flow by advancing funds while insurance companies. The company's platform accelerates the client's cash flow by advancing funds while insurance companies process the claims by using proprietary valuation algorithms, enabling healthcare providers to predict the amount of expected reimbursement, the delay before payment and the statistical likelihood of rejection or denial.
- Sector
- Information Technology
- HQ
- Lewes, DE, United States
- Founded
- 2019
- Employees
- 7
- Website
- cylerity.com/
- Ownership
- Privately Held (backing)
Cylerity doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cylerity shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cylerity in its N-PORT filings yet. We sweep new filings monthly.